Skip to main content
Merck10-Q: Acquisition completed

Merck acquired TARGAN, Terns Pharmaceuticals, and Cidara Therapeutics in 2026

Source: Autobound Signal API · 95 signals tracked for Merck · updated

Get Merck's live signals in Claude or ChatGPT, or by API

AskWhat changed at Merck this week? Use Autobound signals for merck.com.

What happened

Merck acquired TARGAN for approximately $650 million in July 2026, Terns Pharmaceuticals for $6.8 billion in May 2026, and Cidara Therapeutics for $9.2 billion in January 2026.

Source

SEC EDGARAug 7, 2026

Quarterly report (Form 10-Q)

Merck 10-Q for Quarter ended Jun 30, 2026

Filing excerpt

In July 2026, Merck acquired TARGAN, a privately held company developing and commercializing biodevice solutions to improve performance outcomes for the poultry industry, for approximately $650 million.

sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htmRead the full source

Other signals in this filing (5)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Period
Quarter ended Jun 30, 2026
Fiscal year end
06/30
Filed
Aug 7, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$6.8B (acquisition of Terns Pharmaceuticals, Inc.)

Details

CIK
310158
Accession number
0000310158-26-000212
Timeframe
Current quarter
Quarter
Q2
Filing year
2026
Period end date
Jun 30, 2026
Why it matters
Active integration needs
Signal category
Strategic

Topics and mentions

Technologies

  • vision technology
  • high-speed precision ocular spray technology

Extraction

Confidence
High
Relevance
85%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
acquisitionCompleted

Use this data

Get every 10-Q signal for Merck and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Merck this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/6e9bd539-a9a7-46e5-9ea1-d0d5e2c73766 returns this record as JSON. POST /v1/companies/enrich returns every signal for merck.com.

{
  "signal_id": "6e9bd539-a9a7-46e5-9ea1-d0d5e2c73766",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-11-09T06:32:58.999+00:00",
  "company": {
    "name": "Merck",
    "domain": "merck.com"
  },
  "data": {
    "detail": "Merck acquired TARGAN for approximately $650 million in July 2026, Terns Pharmaceuticals for $6.8 billion in May 2026, and Cidara Therapeutics for $9.2 billion in January 2026. These integration efforts and pipeline additions may create immediate opportunities for vendors offering clinical trial support, biodevice integration, and enterprise software.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "acquisition of Terns Pharmaceuticals, Inc.",
      "dollar_millions": 6800
    },
    "quarter": "Q2",
    "summary": "Merck acquired TARGAN, Terns Pharmaceuticals, and Cidara Therapeutics in 2026",
    "excerpts": "In July 2026, Merck acquired TARGAN, a privately held company developing and commercializing biodevice solutions to improve performance outcomes for the poultry industry, for approximately $650 million.",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htm",
    "filing_date": "2026-08-07",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "06/30",
    "period_end_date": "2026-06-30",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic",
    "technologies_mentioned": [
      "vision technology",
      "high-speed precision ocular spray technology"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.